Entering text into the input field will update the search result below

Keep Your Eye On Oncomed Pharmaceuticals

Nov. 13, 2014 9:55 AM ETOMED-OLD, CELG, GSK, BAYZF
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Keep your eyes on shares of OMED heading into next week. I believe the company to have its own idiosyncratic risk/reward profile in a market I believe will be pulling back significantly.

(See my recent piece here, seekingalpha.com/article/2674015-sell-off-coming-prepare-accordingly)

Data will be released next week for preclinical trials and 2015 is expected to be a year full of advanced trial data.

I am long shares of OMED.

  • development stage biotech firm w/ approx. $620m market cap
  • big name partners in Celgene (CELG), Bayer (BAYSY) and GlaxoSmithKline (GSK)
  • raised year end cash balance to over $225 million
  • good revenue growth through milestone payments.
  • costs appear under control, particularly on the SG&A side
  • broad pipeline and upcoming data releases
  • risk/reward favorable at these levels

Check out my charts and Oncomed's pipeline below.

Cheers!

Analyst's Disclosure: The author is long OMED.

The author wrote this article themselves, and it expresses their own opinions. The article should not be considered a recommendation to buy or sell or investment advice. The article is intended to inform the reader of potential investment idea. Personal due diligence is always recommended.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You